Stéphane Chèze

3.1k total citations
46 papers, 1.0k citations indexed

About

Stéphane Chèze is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Stéphane Chèze has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 23 papers in Genetics and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Stéphane Chèze's work include Platelet Disorders and Treatments (14 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Acute Myeloid Leukemia Research (11 papers). Stéphane Chèze is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Acute Myeloid Leukemia Research (11 papers). Stéphane Chèze collaborates with scholars based in France, United States and Belgium. Stéphane Chèze's co-authors include Bertrand Godeau, Philippe Bierling, François Lefrère, Bruno Varet, Olivier Fain, Pierre Fenaux, M Leporrier, Marc Michel, Marie‐José Grange and Cyrille Hulin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Stéphane Chèze

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Chèze France 16 700 372 353 159 157 46 1.0k
Alessio Perrotti Italy 10 387 0.6× 189 0.5× 252 0.7× 85 0.5× 108 0.7× 36 685
Matthieu Mahévas France 21 1.2k 1.8× 402 1.1× 326 0.9× 260 1.6× 65 0.4× 66 1.6k
Potito Rosario Scalzulli Italy 17 577 0.8× 263 0.7× 160 0.5× 159 1.0× 200 1.3× 43 831
Jean‐Marc Zini France 15 492 0.7× 219 0.6× 209 0.6× 126 0.8× 128 0.8× 33 867
Joo-Seop Chung South Korea 14 213 0.3× 155 0.4× 310 0.9× 200 1.3× 211 1.3× 46 690
Masamitsu Karasawa Japan 17 497 0.7× 379 1.0× 210 0.6× 249 1.6× 99 0.6× 78 943
Fatih Demırkan Türkiye 13 302 0.4× 581 1.6× 489 1.4× 220 1.4× 179 1.1× 82 926
Patricia B. Lehane United Kingdom 9 171 0.2× 231 0.6× 298 0.8× 219 1.4× 114 0.7× 20 812
Yukari Shirasugi Japan 16 325 0.5× 222 0.6× 237 0.7× 96 0.6× 172 1.1× 39 630
Ming‐Chung Kuo Taiwan 20 686 1.0× 361 1.0× 301 0.9× 74 0.5× 224 1.4× 84 1.2k

Countries citing papers authored by Stéphane Chèze

Since Specialization
Citations

This map shows the geographic impact of Stéphane Chèze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Chèze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Chèze more than expected).

Fields of papers citing papers by Stéphane Chèze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Chèze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Chèze. The network helps show where Stéphane Chèze may publish in the future.

Co-authorship network of co-authors of Stéphane Chèze

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Chèze. A scholar is included among the top collaborators of Stéphane Chèze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Chèze. Stéphane Chèze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moulis, Guillaume, Sylvain Audia, Louis Terriou, et al.. (2025). Efficacy and safety of dapsone in adult primary immune thrombocytopenia. Blood Advances. 9(8). 1976–1983.
2.
Moulis, Guillaume, Matthieu Mahévas, Jean‐François Viallard, et al.. (2024). Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry. British Journal of Haematology. 204(4). 1476–1482. 4 indexed citations
3.
Mahévas, Matthieu, Jean‐François Viallard, Thibault Comont, et al.. (2023). Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents. Blood. 142(12). 1099–1101. 2 indexed citations
4.
Moulis, Guillaume, Matthieu Mahévas, Jean‐François Viallard, et al.. (2022). Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry. Blood. 140(Supplement 1). 5557–5558. 2 indexed citations
5.
Maître, Elsa, Édouard Cornet, Agathe Debliquis, et al.. (2022). Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy. Journal of Cancer Research and Clinical Oncology. 148(8). 2013–2022. 11 indexed citations
6.
Mageau, Arthur, Louis Terriou, Mikaël Ebbo, et al.. (2021). Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment. American Journal of Hematology. 97(1). 10–17. 22 indexed citations
7.
Michel, Marc, Marco Ruggeri, Tomás José González‐López, et al.. (2020). Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. Blood. 136(26). 3056–3061. 44 indexed citations
8.
Jovenin, Nicolas, Stéphane Chèze, Vincent Launay‐Vacher, et al.. (2019). Nausées-vomissements induits par les traitements anti-cancéreux (NVITAC) : quelle prise en charge en 2018 ? Mise à jour du référentiel AFSOS. Bulletin du Cancer. 106(5). 497–509. 7 indexed citations
9.
Chantepie, Sylvain, Jean-Baptiste Méar, Anne‐Claire Gac, et al.. (2014). Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma. 56(8). 2326–2330. 13 indexed citations
10.
Audemard, A., Thierry Lamy, Benoît Bareau, et al.. (2013). Vasculitis associated with large granular lymphocyte (LGL) leukemia: Presentation and treatment outcomes of 11 cases. Seminars in Arthritis and Rheumatism. 43(3). 362–366. 15 indexed citations
11.
Natarajan‐Amé, Shanti, Sophie Park, Lionel Adès, et al.. (2012). Bortezomib combined with low‐dose cytarabine in Intermediate‐2 and high risk myelodysplastic syndromes. A phase I / II Study by the GFM. British Journal of Haematology. 158(2). 232–237. 12 indexed citations
12.
Khellaf, Mehdi, Jean‐François Viallard, M. Hamidou, et al.. (2012). Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients. Blood. 120(21). 4651–4651. 2 indexed citations
13.
Boysson, Hubert de, et al.. (2012). Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuria. Joint Bone Spine. 80(2). 208–210. 4 indexed citations
14.
Rosé, Christian, Sabine Bréchignac, D. Vassilief, et al.. (2010). Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM. Leukemia Research. 34(7). 864–870. 144 indexed citations
15.
Park, Sophie, Charikleia Kelaïdi, Rosa Sapena, et al.. (2010). Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: A retrospective analysis on 112 patients. Leukemia Research. 34(11). 1430–1436. 46 indexed citations
16.
Chantepie, Sylvain, Dominique Vaur, Christoph Grunau, et al.. (2009). ZAP-70 intron1 DNA methylation status: Determination by pyrosequencing in B chronic lymphocytic leukemia. Leukemia Research. 34(6). 800–808. 18 indexed citations
17.
Godeau, Bertrand, Raphaël Porcher, Olivier Fain, et al.. (2008). Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 112(4). 999–1004. 184 indexed citations
18.
19.
Roulland, Sandrine, Gaël Roué, Hossein Mossafa, et al.. (2001). No BCL-2 protein over expression but BCL-2/IgH rearrangements in B cells of patients with persistent polyclonal B-cell lymphocytosis. The Hematology Journal. 2(4). 228–233. 7 indexed citations
20.
Delcambre, Corinne, Oumédaly Reman, M. Henry‐Amar, et al.. (2000). Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy. European Journal of Nuclear Medicine and Molecular Imaging. 27(2). 176–184. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessio Perrotti Breakdown of academic impact, for papers by Matthieu Mahévas Breakdown of academic impact, for papers by Potito Rosario Scalzulli Breakdown of academic impact, for papers by Jean‐Marc Zini Breakdown of academic impact, for papers by Joo-Seop Chung Breakdown of academic impact, for papers by Masamitsu Karasawa Breakdown of academic impact, for papers by Fatih Demırkan Breakdown of academic impact, for papers by Patricia B. Lehane Breakdown of academic impact, for papers by Yukari Shirasugi Breakdown of academic impact, for papers by Ming‐Chung Kuo
Rankless by CCL
2026